HDL Cholesterol
High-density lipoprotein (HDL) cholesterol is an essential component of the complex equilibrium of cholesterol levels in the human body and is vital for preserving cardiovascular health. We will examine the properties of HDL cholesterol in detail in this extensive guide, including its roles, importance, and the most recent research findings.
HDL cholesterol: what is it?
The lipoprotein known as HDL cholesterol, or the "good" cholesterol, is responsible for returning cholesterol from different tissues to the liver. In contrast to low-density lipoprotein (LDL), high-density lipoprotein (HDL) aids in the removal of extra cholesterol from the blood, promoting a better lipid profile.
Features of HDL Cholesterol Function
· Reverse Cholesterol Transport (RCT): One of HDL's main jobs is to speed up the process of reverse cholesterol transport. By removing extra cholesterol from peripheral tissues and returning it to the liver for excretion, HDL particles stop cholesterol from building up in artery walls.
· Anti-Inflammatory Properties: HDL has anti-inflammatory properties that may lower the chance of developing atherosclerosis. It supports cardiovascular health by regulating the immune system and assisting in the preservation of blood vessel integrity.
Levels of HDL Cholesterol and Risk of Heart Attack
· The Balancing Act: Cardiovascular health must maintain a balance between HDL and LDL cholesterol. Because low levels of HDL may impair the effective elimination of cholesterol from the circulation, they are linked to an increased risk of heart disease.
· The Protective Aspect: It is commonly accepted that having higher HDL levels guards against cardiovascular events. Research indicates that a higher level of HDL cholesterol might be associated with a lower risk of coronary heart disease.
Factors affecting the levels of HDL cholesterol.
· Genetics: HDL cholesterol levels are influenced by genetic factors. Some people may be genetically predisposed to have greater or lower levels of HDL, which might affect their risk of cardiovascular disease in general.
· Lifestyle Decisions: Exercise and food have a major influence on HDL cholesterol levels, among other lifestyle variables. Higher HDL levels are a result of refraining from smoking, eating a diet high in healthy fats, and engaging in regular physical activity.
· Drugs: Several drugs, including fibrates and statins, can affect HDL cholesterol levels. However the effect varies, and each person's reaction to medicine may be unique.
The R-LDL Correlation
· Complementary Roles: Although HDL and LDL are frequently referred to as the "good" and "bad" cholesterol, respectively, it is crucial to understand that both have vital functions in the body. They are a component of the dynamic system that controls the metabolism of fats.
· Optimal Ratios: It is important to strike the right balance between HDL and LDL cholesterol. The ratio of total cholesterol to HDL cholesterol is a more reliable measure of cardiovascular risk, according to experts, so pay attention to it.
Current Studies and Advancements
· HDL Subtypes: Research on the several HDL subtypes and their unique functions in cardiovascular health is still ongoing. Some subtypes may have stronger anti-atherogenic qualities than others.
· Therapeutic techniques: To raise HDL cholesterol levels and improve its functionality, researchers are looking into cutting-edge therapeutic techniques. These methods include food plans, pharmaceuticals, and lifestyle modifications.
Clinical Consequences
· Screening and Monitoring: To determine cardiovascular risk, routine monitoring of cholesterol levels—including HDL—is essential. People with low HDL values who can benefit from focused therapy are identified through screening.
· Individualized Treatment: Personalized methods of controlling cholesterol levels are becoming more popular because of the recognition of the variability in responses to treatments. Optimizing results might be achieved by customizing treatments depending on individual traits.
Omega-3 Fatty Acids
Recent years have seen a significant increase in interest in omega-3 fatty acids because of their potential health advantages, especially in the areas of inflammation management and cardiovascular health.
Types of Fatty Acids Omega-3
Eicosapentaenoic Acid (EPA)
· Long-chain omega-3 fatty acids like EPA are mostly present in fatty seafood like salmon and tuna.
· Research indicates that EPA is essential in lowering the risk of myocardial infarctions.
Docosahexaenoic Acid (DHA)
DHA is another important long-chain omega-3 fatty acid that is found in abundance in fish oil.
· Its involvement in anti-inflammatory reactions and benefit to cardiovascular health is supported by research.
Food-Based Sources
· Saturated Fish: Flavored with both EPA and DHA, omega-3 fatty acids may be found in abundance in salmon, tuna, mackerel, and sardines. It is advised to consume regularly for ideal heart health.
· Plant-Based Resources: Alpha-linolenic acid (ALA), a precursor to EPA and DHA, may be found in abundance in flaxseeds, chia seeds, and walnuts, among other plant-based foods. They add to total omega-3 consumption, even though they are not as powerful as marine sources.
· Supplements with Fish Oil: To make sure that these vital fatty acids are consumed in sufficient amounts, omega-3 supplements made from fish oil are frequently employed.
The recommended dosage varies according to health objectives. When it comes to lowering the risk of sudden cardiac death and overall mortality in those with established heart problems, omega-3 fatty acids are vital constituents. These fats, particularly docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are found in large quantities in fish oil and fatty seafood like tuna and salmon. Walnuts, canola oil, and flaxseed are other food sources.
In addition to their ability to prevent cardiac arrhythmias, omega-3 fatty acids have anti-inflammatory and anti-thrombotic qualities. On the other hand, omega-6 fatty acids, which are present in meat, seeds, and vegetable oils, tend to increase inflammation and blood clotting. In addition, diseases including rheumatoid arthritis, hypertension, and hyperlipidemia are treated with omega-3 fatty acids [1].
When using omega-3 fatty acids, there are no noteworthy drug interactions. The American Heart Association suggests eating fish regularly; for those without a history of heart disease, this means consuming two servings or more each week; for people with heart problems, this means consuming fish every day. A daily dose of around 1 gram of EPA and DHA is recommended for cardioprotection.
Studies show that omega-3 fatty acids, especially EPA and DHA, alter the makeup of immune-related cells. Western diets typically produce cells that have high levels of the pro-inflammatory fatty acid arachidonic acid. On the other hand, EPA, and DHA from marine omega-3 fatty acids, such as those in fish oil, can take the role of arachidonic acid to produce a more anti-inflammatory environment.
Omega-3 fatty acids from diet contain several immune-modulating and anti-inflammatory properties that are important to diseases including stroke, myocardial infarction, atherosclerosis, and sudden death. Research demonstrates their beneficial effects on blood pressure, inflammation, platelet function, cholesterol, and triglycerides. The advantages of omega-3 fatty acids in lowering the risk of coronary heart disease and sudden cardiac death are further supported by epidemiological and clinical research.
The FDA has authorized fish oil, which is enriched in omega-3 fatty acids, to lower triglyceride levels and raise high-density lipoprotein. It has also demonstrated clinically significant antiarrhythmic qualities, most notably in lowering the risk of sudden death in myocardial infarction survivors. This emphasizes how crucial fish oil is to European post-infarction treatment plans.
Particularly in Western nations, current dietary intakes of extremely long-chain omega-3 fatty acids (EPA and DHA) are frequently deficient. Fish oil supplements and fatty fish are good sources. When integrated into the body, these fatty acids affect a number of physiological functions, the composition of cell membranesseveralction of lipid mediators, and the expression of genes, all of which support good health and disease prevention. Increased consumption has been advised since the advantages go beyond heart health to ailments including rheumatoid arthritis [2].
Role of Omega-3 Fatty Acids in Boosting HDL Cholesterol
Research has demonstrated that omega-3 fatty acids enhance the function of high-density lipoprotein (HDL) cholesterol, also referred to as "good" cholesterol. Omega-3 supplementation was observed to increase the size of big HDL and decrease small HDL and non-esterified fatty acids in HDL levels in a randomized, controlled, double-blind clinical experiment. It has also been shown that omega-3 polyunsaturated fatty acids (PUFAs) enhance lipid metabolism by raising HDL cholesterol and lowering triglycerides 2. enhanced lipoprotein lipase (LPL) activity, which is linked to enhanced triglyceride hydrolysis of very low-density lipoprotein (VLDL), can account for the rise in HDL cholesterol caused by omega-3 PUFAs.
Additionally, it has been shown that omega-3 PUFAs stimulate macrophage reverse cholesterol transport, the mechanism by which extra cholesterol is taken up from peripheral tissues and returned to the liver for excretion. In general, it has been shown that omega-3 fatty acids are advantageous for raising HDL cholesterol and lowering the risk of cardiovascular disease.
The risk of cardiovascular disease (CVD) may be influenced by omega-3 polyunsaturated fatty acids (n-3 PUFAs), especially in secondary prevention. These fatty acids influence several molecular processes and mechanisms linked to CVD, such as modifications to the characteristics of the cellular membrane, interactions with proteins and membrane channels, control of gene expression, modification of eicosanoid profiles, and conversion to bioactive metabolites. The effects of n-3 PUFAs on plasma levels of high-density lipoprotein cholesterol (HDL-C) are mild, but they have a beneficial effect on dyslipidemia.
The endogenous route in cholesterol metabolism refers to the manufacture of cholesterol by the liver and extrahepatic tissues, which is then released into bile or circulated as part of lipoproteins. Preventing intracellular cholesterol buildup and the development of atherosclerotic plaque requires efficient cholesterol efflux. The atheroprotective properties of omega-3 polyunsaturated fatty acids (PUFAs), namely eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are attributed to their ability to promote intracellular lipoprotein catabolism, reduce hepatic apolipoprotein B production, stimulate triglyceride clearance, and decrease LDL formation.
Apolipoprotein AI (apoA-I), Paraoxonase-1 (PON1), ATP-Binding Cassette Transporter A1 (ABCA1), ATP-Binding Cassette Transporter G1 (ABCG1), Apolipoprotein E (apoE), Scavenger Receptor Class B Type I (SR-BI), Cholesterol Ester Transfer Protein (CETP), LDL-Receptor (LDLr), Cholesterol 7alpha-Hydroxylase (CYP7A1), ABCG5/G8, and NPC1L1 were all examined in some of the studies. The results imply that n-3 PUFAs may have a beneficial impact on cholesterol efflux pathways, HDL maturation, and antioxidant benefits. They could also improve the excretion of neutral and acidic sterols from the liver and biliary system, which would add to the overall beneficial effect on RCT [3].
Preclinical and Clinical Trials of Omega-3 Fatty Acids
Researchers looked examined the effects of omega-3 fatty acids, which are high in eicosapentaenoic (EPA) and docosahexaenoic (DHA), on HDL function in a trial comprising 147 people at high cardiovascular risk. The participants were randomized into two groups: omega-3 and omega-6. The results showed that omega-3 improved big HDL levels (28.7%) and decreased small HDL levels (−10.6%). Additionally, omega-3 reduced the activity of the cholesteryl ester transfer protein (CETP) (Δ ω-3 = −1.99 pmol/ul/h) and non-esterified fatty acids in HDL (-16.2%). Increases in EPA and DHA in HDL were linked to modifications in paraoxonase-1 (PON1) and Apo AI. Reduced Apo CIII and CETP and elevated Apo CII and PON1 were components of the overall cardioprotective profile [4].
A diet high in omega-3 polyunsaturated fatty acids (PUFAs) was shown to be associated with a decreased incidence of acute myocardial infarction and diabetes mellitus in Northwest Greenland, according to an epidemiological survey. Research indicates that taking supplements of omega-3 polyunsaturated fatty acids lowers blood triglycerides and raises HDL cholesterol, which may help avoid diabetes. Enhancements in glucose and lipid metabolism, anti-platelet activity, anti-inflammatory effects, endothelial function, and stability of plaque are among the causes [5].
The purpose of the randomized, double-blind, placebo-controlled STRENGTH trial is to ascertain if Epanova 4 g daily lowers the risk of cardiovascular events in individuals taking statins and having low HDL-C and hypertriglyceridemia. 13,086 individuals are involved, and the key outcome is the amount of time before the first incident of cardiovascular mortality, myocardial infarction, stroke, coronary revascularization, or unstable angina hospitalization [6].
High-dose marine omega-3 fatty acids have been shown to lower the outcomes of cardiovascular disease, according to the REDUCE-IT experiment. High doses of omega-3 have been shown to have an anti-atherosclerotic effect, delaying the development of atherosclerosis, according to a comprehensive review and meta-analysis of randomized controlled trials [7].
In a clinical experiment, the benefits of co-supplementing with omega-3 fatty acids and vitamin E were investigated in sixty individuals with gestational diabetes mellitus (GDM). In comparison to the placebo group, after 6 weeks the omega-3 plus vitamin E group showed substantial improvements in lipid concentrations, insulin resistance, beta cell activity, and glucose homeostasis measures. Co-supplementing with omega-3 and vitamin E improved the glucose homeostasis indices, serum triglycerides, VLDL and HDL cholesterol levels in women with gestational diabetes mellitus [8].
Comments